Abstract
Pluronic-based core/shell nanoparticles (NPs) were formed using various strategies such as self-assembly and temperature induced-phase transition. To improve their functionality as a nanomedicine for diagnosis and therapy, the vesicle fusion and layer by layer approach were employed. Because of the hydrophilic nature of the Pluronic shell and the relatively small size, Pluronic-based core/shell NPs were used in order to improve their pharmacokinetic behaviors in drugs and in imaging agents. This review will introduce various types of Pluronic-based core/shell NPs according to their preparation method and formation mechanism. The focus will be on the Pluronic-based core/shell NPs for tumor targeting, stimulated release of proteins, and cancer imaging capabilities.
Keywords: Antitumor efficacy, cancer targetability, chitosan/heparin composite, core/shell nanoparticles, enhanced permeability and retention effect, layer-by-layer approach, molecular imaging agent, Pluornics, Pluronic/liposome composite nanoparticles, polyethylene glycol, protein drug, self-assembly, temperature-induced phase transition, vesicle fusion.
Current Medicinal Chemistry
Title:Pluronic-Based Core/Shell Nanoparticles for Drug Delivery and Diagnosis
Volume: 20 Issue: 28
Author(s): Yon Woo Jung, Hwanbum Lee, Jae Yeon Kim, Eun Jin Koo, Keun Sang Oh and Soon Hong Yuk
Affiliation:
Keywords: Antitumor efficacy, cancer targetability, chitosan/heparin composite, core/shell nanoparticles, enhanced permeability and retention effect, layer-by-layer approach, molecular imaging agent, Pluornics, Pluronic/liposome composite nanoparticles, polyethylene glycol, protein drug, self-assembly, temperature-induced phase transition, vesicle fusion.
Abstract: Pluronic-based core/shell nanoparticles (NPs) were formed using various strategies such as self-assembly and temperature induced-phase transition. To improve their functionality as a nanomedicine for diagnosis and therapy, the vesicle fusion and layer by layer approach were employed. Because of the hydrophilic nature of the Pluronic shell and the relatively small size, Pluronic-based core/shell NPs were used in order to improve their pharmacokinetic behaviors in drugs and in imaging agents. This review will introduce various types of Pluronic-based core/shell NPs according to their preparation method and formation mechanism. The focus will be on the Pluronic-based core/shell NPs for tumor targeting, stimulated release of proteins, and cancer imaging capabilities.
Export Options
About this article
Cite this article as:
Jung Woo Yon, Lee Hwanbum, Kim Yeon Jae, Koo Jin Eun, Oh Sang Keun and Yuk Hong Soon, Pluronic-Based Core/Shell Nanoparticles for Drug Delivery and Diagnosis, Current Medicinal Chemistry 2013; 20 (28) . https://dx.doi.org/10.2174/09298673113209990036
DOI https://dx.doi.org/10.2174/09298673113209990036 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gender Differences in Hemodynamic Regulation and Cardiovascular Adaptations to Dynamic Exercise
Current Cardiology Reviews Modulation of Cardiac and Hepatic Cytochrome P450 Enzymes During Heart Failure
Current Drug Metabolism PET Imaging of Beta-Adrenoceptors in Human Brain: A Realistic Goal or a Mirage?
Current Pharmaceutical Design Purine Ionotropic (P2X) Receptors
Current Pharmaceutical Design Microsomal Prostaglandin E Synthase: A Key Enzyme in PGE2 Biosynthesis and Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents A Review of Therapeutic Effects of Curcumin
Current Pharmaceutical Design Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric Diseases
CNS & Neurological Disorders - Drug Targets Vascular Progenitor Cells in the Development of Transplant Arteriopathy
Current Genomics Peptides as Signaling Inhibitors for Mammalian MAP Kinase Cascades
Current Pharmaceutical Design Growing Collateral Arteries On Demand
Recent Patents on Cardiovascular Drug Discovery Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells
Recent Patents on Regenerative Medicine Antiplatelet Treatment in Stroke: New Insights
Current Pharmaceutical Design Nitric Oxide and Dietary Factors: Part V Summary/Conclusion and References
Vascular Disease Prevention (Discontinued) Role of the RAS in Pancreatic Cancer
Current Cancer Drug Targets Anabolic Androgenic Steroids Abuse and Liver Toxicity
Mini-Reviews in Medicinal Chemistry Therapeutic Potential of Coagonists of Glucagon and GLP-1
Cardiovascular & Hematological Agents in Medicinal Chemistry Serum Amyloid A and Its Potential Physiological / Pathological Functions - an Overview of Patents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Levosimendan for Heart-Operated Patients: What is the State of the Art?
Recent Patents on Cardiovascular Drug Discovery Antioxidant Properties and Associated Mechanisms of Salicylates
Current Medicinal Chemistry New Frontiers in the Management of Acute Coronary Syndromes: Cangrelor and Elinogrel
Recent Patents on Cardiovascular Drug Discovery